{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T03:33:41Z","timestamp":1758944021342},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OTT"],"DOI":"10.2147\/ott.s13052","type":"journal-article","created":{"date-parts":[[2010,11,11]],"date-time":"2010-11-11T02:27:39Z","timestamp":1289442459000},"page":"205","source":"Crossref","is-referenced-by-count":1,"title":["Indirect comparisons of second-generation tyrosine kinase inhibitors in CML: case study using baseline population characteristics"],"prefix":"10.2147","author":[{"given":"Kimbach","family":"Carpiuc","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2010,10]]},"container-title":["OncoTargets and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=7903","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T22:11:26Z","timestamp":1477865486000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/indirect-comparisons-of-second-generation-tyrosine-kinase-inhibitors-i-peer-reviewed-article-OTT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/ott.s13052","relation":{},"ISSN":["1178-6930"],"issn-type":[{"value":"1178-6930","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}